Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Emergent BioSolutions Inc. Common Stock (NY:EBS)

7.110 +0.510 (+7.73%)
Streaming Delayed Price Updated: 11:05 AM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Emergent BioSolutions Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Contrarian Calls: 7 Analyst ‘Sell’ Ratings That Should Be ‘Buys’
While it’s usually a good idea to trust Wall Street’s top experts, sometimes, it’s worthwhile to consider contrarian analyst picks. 
Via InvestorPlace
Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
From Emergent BioSolutions
Via GlobeNewswire
Earnings Preview For Emergent BioSolutions
Via Benzinga
Why Emergent BioSolutions Stock Is Tumbling Today
The healthcare stock will soon be booted from an index tracked by several ETFs. 
Via The Motley Fool
Why Is Icosavax (ICVX) Stock Up 46% Today?
Icosavax stock is up on Tuesday as investors react to an acquisition deal with AstraZeneca that values ICVX between $15 and $20 per share. 
Via InvestorPlace
EBS Stock Earnings: Emergent BioSolutions Misses EPS, Beats Revenue for Q3 2023
EBS stock results show that Emergent BioSolutions missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2023. 
Via InvestorPlace
What's Going On With Emergent Biosolutions Stock?
Emergent Biosolutions Inc (NYSE: EBS) shares initially traded higher Tuesday before pulling back and turning negative. 
Via Benzinga
Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions (EBS) Q3 2023 Earnings Call Transcript
EBS earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Emergent BioSolutions Reports Third Quarter 2023 Financial Results
From Emergent BioSolutions
Via GlobeNewswire
UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 8, 2023
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
From Emergent BioSolutions
Via GlobeNewswire
Opioid Overdose Treatment: Walgreens To Stock FDA-Approved NARCAN Spray
Walgreens Boots Alliance Inc (NASDAQ: WBA) said 
Via Benzinga
Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency
From Emergent BioSolutions
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2023
Via Benzinga
Why Macy's Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares jumped 42.8% to $5.60 after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease. 
Via Benzinga
Why ProMIS Neurosciences Shares Are Trading Higher By 33%; Here Are 20 Stocks Moving Premarket
Gainers Axcella Health Inc. (NASDAQ: AXLA) shares gained 65% to $0.2887 in pre-market trading after gaining 12% on Monday. The company recently posted a narrower-than-expected quarterly loss. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off Tuesday with a breakdown of the biggest pre-market stock movers investors will want to keep an eye on! 
Via InvestorPlace
PureCycle Technologies, Canadian Solar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded higher this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Emergent BioSolutions (EBS) Q2 2023 Earnings Call Transcript
EBS earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Emergent BioSolutions Reports Financial Results for Second Quarter 2023
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position
From Emergent BioSolutions
Via GlobeNewswire
Caterpillar, Oshkosh, AudioCodes And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Nasdaq Composite falling around 70 points on Tuesday. Here are some big stocks recording gains in today’s session. American Superconductor Corporation (NASDAQ: AMSC)... 
Via Benzinga
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Emergent Biosolutions Stock Is Surging After The Close
Emergent Biosolutions Inc (NYSE: EBS) shares are trading higher in Monday's after-hours session after the company was awarded a 10-year contract for 
Via Benzinga
Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola
From Emergent BioSolutions
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.